Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-13 4:30 pm Sale | 2026-06-30 | 13G | ASCENDIS PHARMA A/S SHS USD ASND | Artisan Partners Asset Management Inc. | 2,634,024 4.200% | -591,861 (-18.35%) | Filing History |
| 2026-05-15 12:36 pm Sale | 2026-03-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | JANUS HENDERSON GROUP Ltd. JHG | 3,719,452 6.000% | -603,607 (-13.96%) | Filing History |
| 2026-05-14 12:52 pm Sale | 2026-03-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | Capital International Investors | 2,013,285 3.200% | -1,095,940 (-35.25%) | Filing History |
| 2026-05-07 11:03 am Purchase | 2026-04-30 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | T. Rowe Price Investment Management, Inc. | 6,506,219 10.500% | 344,177 (+5.59%) | Filing History |
| 2026-05-07 10:32 am Purchase | 2026-03-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | T. Rowe Price Investment Management, Inc. | 6,162,042 9.900% | 3,494,479 (+131.00%) | Filing History |
| 2026-05-06 11:00 am Sale | 2026-03-31 | 13G | ASCENDIS PHARMA A/S SHS USD ASND | FMR LLC | 3,852,101 6.600% | -794,842 (-17.10%) | Filing History |
| 2026-02-11 10:57 am Sale | 2025-12-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | WESTFIELD CAPITAL MANAGEMENT CO LP | 5,185,696 8.480% | -342,543 (-6.20%) | Filing History |
| 2026-02-03 2:00 pm Sale | 2025-12-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | Artisan Partners Asset Management Inc. | 3,225,885 5.200% | -1,185,226 (-26.87%) | Filing History |
| 2025-11-14 12:18 pm Sale | 2025-09-30 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | T. Rowe Price Investment Management, Inc. | 2,667,563 4.800% | -915,983 (-25.56%) | Filing History |
| 2025-11-14 11:54 am Sale | 2025-09-30 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | JANUS HENDERSON GROUP Ltd. JHG | 4,323,059 7.800% | -104,733 (-2.37%) | Filing History |
| 2025-08-14 12:12 pm Purchase | 2025-06-30 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | T. Rowe Price Investment Management, Inc. | 3,583,546 6.400% | 529,722 (+17.35%) | Filing History |
| 2025-08-14 10:57 am Sale | 2025-06-30 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | JANUS HENDERSON GROUP Ltd. JHG | 4,427,792 8.000% | -69,243 (-1.54%) | Filing History |
| 2025-08-13 12:49 pm Purchase | 2025-06-30 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | Capital International Investors | 3,109,225 5.600% | 3,109,225 (New Position) | Filing History |
| 2025-05-14 11:59 am Purchase | 2025-03-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | JANUS HENDERSON GROUP Ltd. JHG | 4,497,035 7.400% | 116,653 (+2.66%) | Filing History |
| 2025-05-14 10:47 am Purchase | 2025-03-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | T. Rowe Price Investment Management, Inc. | 3,053,824 5.000% | 1,288,782 (+73.02%) | Filing History |
| 2025-05-12 10:24 am Sale | 2025-03-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | FMR LLC | 4,646,943 8.000% | -467,426 (-9.14%) | Filing History |
| 2025-02-14 11:54 am Purchase | 2024-12-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | JANUS HENDERSON GROUP Ltd. JHG | 4,380,382 7.200% | 193,688 (+4.63%) | Filing History |
| 2025-02-11 09:15 am Purchase | 2024-12-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | WESTFIELD CAPITAL MANAGEMENT CO LP | 5,528,239 9.180% | 1,453,025 (+35.66%) | Filing History |
| 2025-02-10 5:13 pm Purchase | 2024-12-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | WESTFIELD CAPITAL MANAGEMENT CO LP | 4,075,214 9.180% | 44,580 (+1.11%) | Filing History |
| 2024-11-14 5:46 pm Sale | 2024-09-30 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | RA Capital Management, L.P. | 9,710,428 16.100% | -396,972 (-3.93%) | Filing History |